ArticleCurrent microbiology2025
Multifunctional Silver Nanoparticles Synthesized via Exiguobacterium aurantiacum: Applications in Dye Remediation, Anticancer and Antibacterial Activity.
Article in Current microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Environmental applications of silver nanoparticles: state-of-the-art review and emerging trends.Beilstein journal of nanotechnology · 2026Review
- Synthesis and characterization of honey bee venom-loaded calcium oxide nanocomposites and evaluation of their cytotoxic (MCF-7) and antifungal activity.Discover nano · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The study investigates adaptations of photovoltaic solar panel isolates and their applications. Exiguobacterium aurantiacum (KKOHNGU1) was extracted from a PV solar panel in Patan, Gujarat, India. The objective was to synthesize and characterize silver nanoparticles (AgNPs) using E. aurantiacum (KKOHNGU1) to evaluate their potential in environmental remediation, anticancer, and antibacterial activities. MALDI-TOF analysis identified secondary metabolites as stabilizing and reducing agents. AgNPs were characterized using UV-visible spectroscopy (peak at 425 nm), X-ray diffraction (peaks at 27.6°, 32.12°, and 46.06°), Fourier transform infrared spectroscopy field emission scanning electron microscopy and energy-dispersive spectroscopy, shows spherical crystalline AgNPs with a mean size (121.44 nm). AgNPs (15 mg/mL) showed antibacterial activities, especially against S. aureus, with a 17.5 mm zone of inhibition MIC (2-32 µg/mL), and MBC (32-150 µg/mL). The MTT assay revealed anticancer activity of AgNPs on the MDA-MB-231 breast cancer cell line with an IC
Indexed as
Identifiers
40372469What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.